Study on the influence of improved precise sampling process of surgical specimens on the detection results of HER2 in gastric cancer

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2100045131

Enrollment

Unknown

Registered

2021-04-07

Start date

2021-04-06

Completion date

Unknown

Last updated

2021-11-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

gastric cancer

Interventions

observation group:Improved sampling and fixation process

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.Diagnosis of gastric adenocarcinoma; 2.Patients underwent radical or palliative gastrectomy; 3.Sign informed consent.

Exclusion criteria

Exclusion criteria: Patients who only underwent gastroscopy biopsy.

Design outcomes

Primary

Measure	Time frame
Positive rate of HER2 test;	—

Countries

China

Contacts

Public ContactLiu Kai

Cancer Hospital Affiliated to Shandong First Medical University

954947157@qq.com+86 13954117480

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026